Prescription Drug News and Research

RSS

Improvements to Medicare prescription drug program benefit MS patients in the 'donut hole'

As the average cost of MS in the United States is nearly $70,000 a year, with the overall annual economic cost of MS being an estimated $28 billion, people living with MS face high out-of-pocket costs even when covered by health insurance.

30 May 2011

Blue Cross and Blue Shield FEP pharmacy benefit management program awarded to CVS Caremark

CVS Caremark Corporation today announced that it has been awarded a three-year contract to provide integrated pharmacy benefit services for the Blue Cross and Blue Shield Government-wide Service Benefit Plan, also known as the Federal Employee Program (FEP), based on the best overall value.

27 May 2011

Lawmakers jockey for position in Medicare debate

Political and policy-oriented Medicare skirmishes continue on Capitol Hill as members hear from their constituents on the question of the program's future, and some lawmakers say it's time for "an adult conversation." Also, the Senate is likely to vote this week on the House-passed GOP budget.

24 May 2011

Millennium Laboratories founder to be honored as 2011 Ernst & Young Entrepreneur for pain care

Millennium Laboratories, a leading provider of medication monitoring services to physicians and staff treating chronic pain, announced today that James Slattery, CEO and founder, is a regional finalist for the Ernst & Young Entrepreneur of the Year 2011 San Diego region.

23 May 2011

Verizon Wireless and Medco unveil mobile medication app with real-time patient-specific drug safety

Verizon Wireless and Medco Health Solutions, Inc. have announced a mobile application that can instantly guide patients and their doctors to the lowest-cost prescription drug to meet their health needs and help them identify potentially harmful drug interactions. Available now on Verizon Wireless Android handsets and BlackBerry devices, the new Medco Pharmacy mobile app delivers critical information to help Medco members manage their prescription medications.

22 May 2011

Editorial boards, columnists have lots to say about Gingrich and Medicare

Newt Gingrich was right — the first time. The former House speaker and current presidential candidate has retreated under a barrage of criticism, but he had two things to say on NBC's "Meet The Press" that were correct even if politically ill-advised.

21 May 2011

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

The American Pain Society, www.ampainsoc.org, today honored the recipients of its fifth annual Clinical Centers of Excellence in Pain Management Awards recognizing the nation's outstanding pain care centers.

21 May 2011

Roundup: Private prison costs; GOP lawmakers in Wis. break with Governor on cuts to senior services

The conviction that private prisons save money helped drive more than 30 states to turn to them for housing inmates. But Arizona shows that popular wisdom might be wrong: Data there suggest that privately operated prisons can cost more to operate than state-run prisons — even though they often steer clear of the sickest, costliest inmates (Oppel, 5/18).

20 May 2011

Omeros advances OMS103HP and OMS302 into Phase 3 clinical programs

Omeros Corporation today announced that it is advancing two of its product candidates from its PharmacoSurgery platform – OMS103HP for arthroscopic meniscectomy and OMS302 for intra-ocular lens replacement surgery – into Phase 3 clinical development programs.

19 May 2011

Generic drugs to rule the market in the near future: Experts

According to the latest estimates for global drug sales, generic drug makers are going to be in for bumper profits. The growth in generics is expected to depress overall ‘pharma’ sales growth, as lower-priced copies replace top-dollar brand names. In fact, global sales growth could be reduced by half over the next five years, say experts.

19 May 2011

Kindred Healthcare plans $550 million senior notes offering

Kindred Healthcare, Inc. today announced that it is planning to issue an aggregate principal amount of up to $550 million of senior notes due 2019 to qualified institutional buyers in accordance with Rule 144A under the Securities Act of 1933, as amended and to certain non-United States persons in offshore transactions in accordance with Regulation S under the Securities Act.

16 May 2011

Positive results from EXPAREL Phase 3 study to be presented at ASCRS Annual Scientific Meeting

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced that positive results from its Phase 3 study evaluating EXPAREL in patients following hemorrhoidectomy will be presented at the 2011 American Society of Colon and Rectal Surgeons Annual Scientific Meeting in Vancouver, British Columbia.

16 May 2011

pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment

pSivida Corp., a leader in developing sustained release, drug delivery products for treatment of back-of-the-eye diseases, today announced that its licensee, Alimera Sciences, Inc., resubmitted a New Drug Application for the investigational drug ILUVIEN for the treatment of diabetic macular edema (DME) to the U.S. Food and Drug Administration (FDA) on May 12, 2011 to address questions raised in the Complete Response Letter (CRL) Alimera received in December 2010.

16 May 2011

HHS dual-eligible program seeks to lower states' Medicaid costs

The centerpiece of the program, which HHS says could result in savings of billions of dollars a year, would give states access to data detailing how Medicaid populations use Medicare services.

13 May 2011

Two DIFICID Phase 3 trial data in C. difficile infection presented at AGS Annual Meeting

Optimer Pharmaceuticals today announced the presentation of an additional analysis of data from the company's two Phase 3 clinical trials of DIFICID, an investigational antibiotic for the treatment of Clostridium difficile Infection, at the American Geriatric Society (AGS) Annual Meeting held in National Harbor, Maryland.

13 May 2011

HHS announces new initiatives to improve patient care and reduce Medicaid costs

The U.S. Department of Health and Human Services today announced a series of initiatives to work with states to save money and better coordinate care for the 9 million Americans enrolled in both Medicare and Medicaid.

12 May 2011

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Pacira Pharmaceuticals, Inc., an emerging specialty pharmaceutical company, today announced financial results for the first quarter ended March 31, 2011, provided an update on the execution of its pre-commercial and launch strategies for EXPAREL, and reiterated 2011 financial guidance.

11 May 2011

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Optimer Pharmaceuticals, Inc. today announced the presentation of two abstracts at the 2011 Digestive Disease Week conference highlighting additional analyses of data from Phase 3 trials of DIFICID, an investigational product for the treatment of Clostridium difficile infection.

11 May 2011

Two DIFICID Phase 3 study data in C. difficile presented at ECCMID conference

Optimer Pharmaceuticals, Inc. today announced the presentation of two abstracts at the 21st European Congress of Clinical Microbiology and Infectious Diseases conference in Milan, Italy highlighting additional analyses of the Phase 3 data of DIFICID for the treatment of Clostridium difficile infection.

11 May 2011

Health Net achieves reaccreditation from URAC

Health Net Federal Services, LLC, part of the Government Contracts segment of Health Net, Inc., announced today it has been awarded full Health Network Reaccreditation, effective July 1, 2011 - July 1, 2014, from URAC, a Washington, DC-based health care accrediting organization that establishes quality standards for the health care industry.

10 May 2011

Prescription Drug News and Research

Improvements to Medicare prescription drug program benefit MS patients in the 'donut hole'

Blue Cross and Blue Shield FEP pharmacy benefit management program awarded to CVS Caremark

Lawmakers jockey for position in Medicare debate

Millennium Laboratories founder to be honored as 2011 Ernst & Young Entrepreneur for pain care

Verizon Wireless and Medco unveil mobile medication app with real-time patient-specific drug safety

Editorial boards, columnists have lots to say about Gingrich and Medicare

APS honors recipients of Clinical Centers of Excellence in Pain Management Awards

Roundup: Private prison costs; GOP lawmakers in Wis. break with Governor on cuts to senior services

Omeros advances OMS103HP and OMS302 into Phase 3 clinical programs

Generic drugs to rule the market in the near future: Experts

Kindred Healthcare plans $550 million senior notes offering

Positive results from EXPAREL Phase 3 study to be presented at ASCRS Annual Scientific Meeting

pSivida resubmits ILUVIEN NDA to FDA for diabetic macular edema treatment

HHS dual-eligible program seeks to lower states' Medicaid costs

Two DIFICID Phase 3 trial data in C. difficile infection presented at AGS Annual Meeting

HHS announces new initiatives to improve patient care and reduce Medicaid costs

Pacira Pharmaceuticals reports net loss of $9.8 million for first quarter 2011

Two DIFICID Phase 3 trial data in C. difficile presented at DDW conference

Two DIFICID Phase 3 study data in C. difficile presented at ECCMID conference

Health Net achieves reaccreditation from URAC

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News